Guorong Li1, Sina Farsiu2, Stephanie J Chiu3, Pedro Gonzalez1, Elke Lütjen-Drecoll4, Darryl R Overby5, W Daniel Stamer2. 1. Department of Ophthalmology, Duke University, Durham, North Carolina, United States. 2. Department of Ophthalmology, Duke University, Durham, North Carolina, United States Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States. 3. Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States. 4. Department of Anatomie II, University Erlangen-Nürnberg, Germany. 5. Department of Bioengineering, Imperial College London, London, United Kingdom.
Abstract
PURPOSE: The goal was to assess effects of IOP and pilocarpine-induced ciliary muscle contraction on conventional outflow pathway tissues in living anesthetized mice. METHODS: Intraocular pressure was controlled by intracameral cannulation of mouse eyes while imaging using spectral-domain optical coherence tomography (SD-OCT). Time-lapse sagittal SD-OCT sections through Schlemm's canal (SC) were acquired while changing IOP stepwise between 10 and 45 mm Hg. After topical application of 1% pilocarpine, the series of IOP steps and imaging were repeated. Effects of pilocarpine on IOP and outflow facility in living mice were verified by rebound tonometry and flow measurements at three different IOPs, respectively. In vivo OCT images were compared with eyes analyzed by standard histology. RESULTS: In living mice imaged by SD-OCT, the lumen of SC progressively collapsed with increasing IOP, reaching near complete closure at 20 mm Hg. Schlemm's canal collapse was reversible, with the lumen opening within minutes after returning IOP from 45 to 10 mm Hg. Pilocarpine-induced ciliary muscle contraction changed SC lumen area by 131.6% ± 21.0% compared with untreated controls at 10 mm Hg, opened the trabecular meshwork, and prevented complete collapse of the SC lumen at higher pressures. Similar results were observed by standard histology. Pilocarpine increased outflow facility 4-fold (P = 0.02) and lowered IOP (16.46 ± 2.23 vs. 11.08 ± 2.28 mm Hg, P = 0.03). CONCLUSIONS: Spectral-domain OCT was effective at visualizing changes in SC lumen in living mice. Results with pilocarpine are consistent with the concept that a primary role for the ciliary muscle is to prevent collapse of SC. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: The goal was to assess effects of IOP and pilocarpine-induced ciliary muscle contraction on conventional outflow pathway tissues in living anesthetized mice. METHODS: Intraocular pressure was controlled by intracameral cannulation of mouse eyes while imaging using spectral-domain optical coherence tomography (SD-OCT). Time-lapse sagittal SD-OCT sections through Schlemm's canal (SC) were acquired while changing IOP stepwise between 10 and 45 mm Hg. After topical application of 1% pilocarpine, the series of IOP steps and imaging were repeated. Effects of pilocarpine on IOP and outflow facility in living mice were verified by rebound tonometry and flow measurements at three different IOPs, respectively. In vivo OCT images were compared with eyes analyzed by standard histology. RESULTS: In living mice imaged by SD-OCT, the lumen of SC progressively collapsed with increasing IOP, reaching near complete closure at 20 mm Hg. Schlemm's canal collapse was reversible, with the lumen opening within minutes after returning IOP from 45 to 10 mm Hg. Pilocarpine-induced ciliary muscle contraction changed SC lumen area by 131.6% ± 21.0% compared with untreated controls at 10 mm Hg, opened the trabecular meshwork, and prevented complete collapse of the SC lumen at higher pressures. Similar results were observed by standard histology. Pilocarpine increased outflow facility 4-fold (P = 0.02) and lowered IOP (16.46 ± 2.23 vs. 11.08 ± 2.28 mm Hg, P = 0.03). CONCLUSIONS: Spectral-domain OCT was effective at visualizing changes in SC lumen in living mice. Results with pilocarpine are consistent with the concept that a primary role for the ciliary muscle is to prevent collapse of SC. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Alexandra Boussommier-Calleja; Jacques Bertrand; David F Woodward; C Ross Ethier; W Daniel Stamer; Darryl R Overby Journal: Invest Ophthalmol Vis Sci Date: 2012-08-24 Impact factor: 4.799
Authors: Yuan Lei; Darryl R Overby; Alexandra Boussommier-Calleja; W Daniel Stamer; C Ross Ethier Journal: Invest Ophthalmol Vis Sci Date: 2011-03-29 Impact factor: 4.799
Authors: Jason Y H Chang; W Daniel Stamer; Jacques Bertrand; A Thomas Read; Catherine M Marando; C Ross Ethier; Darryl R Overby Journal: Am J Physiol Cell Physiol Date: 2015-06-03 Impact factor: 4.249
Authors: Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan Journal: Invest Ophthalmol Vis Sci Date: 2014-04-24 Impact factor: 4.799
Authors: Darryl R Overby; Jacques Bertrand; Ozan-Yüksel Tektas; Alexandra Boussommier-Calleja; Martin Schicht; C Ross Ethier; David F Woodward; W Daniel Stamer; Elke Lütjen-Drecoll Journal: Invest Ophthalmol Vis Sci Date: 2014-07-15 Impact factor: 4.799
Authors: Guorong Li; Heather Schmitt; William M Johnson; Chanyoung Lee; Iris Navarro; Jenny Cui; Todd Fleming; María Gomez-Caraballo; Michael H Elliott; Joseph M Sherwood; Michael A Hauser; Sina Farsiu; C Ross Ethier; W Daniel Stamer Journal: FASEB J Date: 2020-07-05 Impact factor: 5.191
Authors: Alex S Huang; Akram Belghith; Anna Dastiridou; Vikas Chopra; Linda M Zangwill; Robert N Weinreb Journal: J Biomed Opt Date: 2017-06-01 Impact factor: 3.170
Authors: Guorong Li; Dibyendu Mukherjee; Iris Navarro; Nicole E Ashpole; Joseph M Sherwood; Jinlong Chang; Darryl R Overby; Fan Yuan; Pedro Gonzalez; Casey C Kopczynski; Sina Farsiu; W Daniel Stamer Journal: Eur J Pharmacol Date: 2016-04-13 Impact factor: 4.432